Elza Friedländer
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Glycosylation and Glycoproteins Research 2
- Ion channel regulation and function 1
- Oncology 4
- HER2/EGFR in Cancer Research 3
- Co-authors
- Péter Nagy (2 shared papers)Thomas M. Jovin (2 shared papers)Anita I. Kapanen (1 shared paper)Kermit L. Carraway (1 shared paper)Minna Tanner (1 shared paper)Jorma Isola (1 shared paper)György Vereb (4 shared papers)János Szöllõsi (2 shared papers)
- Journals
- Cytometry Part A (2 papers)American Journal of Clinical Pathology (1 paper)European Journal of Pharmaceutical Sciences (1 paper)Immunology Letters (1 paper)Cancer Research (1 paper)
- Partner nations
- HungaryGermanyUnited States
In The Last Decade
Elza Friedländer
7 papers receiving 518 citations
Peers
Comparison fields: 5 of 60
- Oncology 370
- Radiology, Nuclear Medicine and Imaging 293
- Immunology and Allergy 40
- Molecular Biology 223
- Genetics 27
Countries citing papers authored by Elza Friedländer
This map shows the geographic impact of Elza Friedländer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elza Friedländer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elza Friedländer more than expected).
Fields of papers citing papers by Elza Friedländer
This network shows the impact of papers produced by Elza Friedländer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elza Friedländer. The network helps show where Elza Friedländer may publish in the future.
Co-authors
The 25 scholars most cited alongside Elza Friedländer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 392 | |
| 2 | 2008 | 53 | |
| 3 | 2014 | 28 | |
| 4 | 2006 | 26 | |
| 5 | 2005 | 16 | |
| 6 | 2006 | 8 | |
| 7 | Quantitative and functional assay of MDR1/P170-mediated MDR in ascites cells of patients with ovarian cancer. | 2005 | 7 |
About Elza Friedländer
Elza Friedländer is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Surgery, having authored 7 papers that have together received 530 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Glycosylation and Glycoproteins Research (2 papers), Cardiac electrophysiology and arrhythmias (1 paper), Ion channel regulation and function (1 paper), IgG4-Related and Inflammatory Diseases (1 paper), Reproductive System and Pregnancy (1 paper) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Oncology (370 citations), Radiology, Nuclear Medicine and Imaging (293 citations), Immunology and Allergy (40 citations), Molecular Biology (223 citations) and Genetics (27 citations). Elza Friedländer has collaborated with scholars based in Hungary, Germany and United States. Frequent co-authors include Péter Nagy, Thomas M. Jovin, Anita I. Kapanen, Kermit L. Carraway, Minna Tanner, Jorma Isola, György Vereb, János Szöllõsi, Márk Barok and Laura Louzao-Martinez. Their work appears in journals such as Cytometry Part A, American Journal of Clinical Pathology, European Journal of Pharmaceutical Sciences, Immunology Letters and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.